152 related articles for article (PubMed ID: 3497139)
41. DQw1 beta gene from HLA-DR2-Dw12 consists of six exons and expresses multiple DQw1 beta polypeptides through alternative splicing.
Tsukamoto K; Yasunami M; Kimura A; Inoko H; Ando A; Hirose T; Inayama S; Sasazuki T
Immunogenetics; 1987; 25(5):343-6. PubMed ID: 3494674
[No Abstract] [Full Text] [Related]
42. Molecular complexity of HLA-DQw3: the TA10 determinant is located on a subset of DQw3 beta chains.
Radka SF; Scott RG; Stewart SJ
Hum Immunol; 1987 Apr; 18(4):287-300. PubMed ID: 2437090
[TBL] [Abstract][Full Text] [Related]
43. Identification with the monoclonal antibody 26.163 of a determinant shared by the beta chains of the gene products of the HLA-DR, DQ, and DP loci.
Igarashi M; Gebhard DH; Chen YX; Safai B; Evans RL; Ferrone S
Hum Immunol; 1986 Aug; 16(4):347-55. PubMed ID: 2428781
[TBL] [Abstract][Full Text] [Related]
44. Simplification of two-dimensional gel patterns of HLA class II antigens.
Rust NA; McMichael AJ
Tissue Antigens; 1986 Aug; 28(2):72-83. PubMed ID: 3462963
[TBL] [Abstract][Full Text] [Related]
45. Functional relationships between HLA-DR2-short/FJO, DB9, and AZH as defined by DR- and DQ-restricted influenza-specific cloned T cells.
Zeliszewski D; Sterkers G; Brautbar C; Betuel H; Layrisse Z; Levy JP
Immunogenetics; 1987; 26(1-2):107-10. PubMed ID: 3497098
[No Abstract] [Full Text] [Related]
46. Oligonucleotide-genotyping as a method of detecting the HLA-DR2 (DRw15)-Dw2, -DR2 (DRw15)-Dw12, -DR4-Dw15, and -DR4-D"KT2" haplotypes in the Japanese population.
Obata F; Ito I; Kaneko T; Ohkubo M; Ishimoto AL; Abe A; Kashiwagi N
Tissue Antigens; 1989 May; 33(5):550-8. PubMed ID: 2799805
[TBL] [Abstract][Full Text] [Related]
47. Molecular diversity of HLA-DQ. DQ alpha and beta chain isoelectric point differences and their relation to serologically defined HLA-DQ allospecificities.
Bontrop RE; Baas EJ; Otting N; Schreuder GM; Giphart MJ
Immunogenetics; 1987; 25(5):305-12. PubMed ID: 3570381
[TBL] [Abstract][Full Text] [Related]
48. HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes.
Sterkers G; Zeliszewski D; Chaussée AM; Deschamps I; Font MP; Freidel C; Hors J; Betuel H; Dausset J; Levy JP
Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6473-7. PubMed ID: 2901099
[TBL] [Abstract][Full Text] [Related]
49. DR2-negative narcolepsy.
Andreas-Zietz A; Keller E; Scholz S; Albert ED; Roth B; Nevsimalova S; Sonka K; Docekal P; Ivaskova E; Schulz H
Lancet; 1986 Sep; 2(8508):684-5. PubMed ID: 2876150
[No Abstract] [Full Text] [Related]
50. Analysis of gene structure and antigen determinants of DR2 antigens using DR gene transfer into mouse L cells.
Kawai J; Ando A; Sato T; Nakatsuji T; Tsuji K; Inoko H
J Immunol; 1989 Jan; 142(1):312-7. PubMed ID: 2462589
[TBL] [Abstract][Full Text] [Related]
51. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
[TBL] [Abstract][Full Text] [Related]
52. Mapping of the HLA-D region by pulsed-field gel electrophoresis: size variation in the DQ-DR interval.
Inoko H; Ando A; Tsuji K
Tokai J Exp Clin Med; 1990 May; 15(2-3):253-60. PubMed ID: 2130532
[TBL] [Abstract][Full Text] [Related]
53. Molecular characterization of a recombinant HLA-DR1/DR2 haplotype.
Bidwell JL; Bidwell EA; Dupont E; Andrien M; Bouillenne C; Klouda PT; Bradley BA
Hum Immunol; 1992 Apr; 33(4):289-93. PubMed ID: 1353488
[TBL] [Abstract][Full Text] [Related]
54. Biochemical dissection of DRw6 related epitopes using monoclonal antibodies.
Johnson JP; Wank R
Hum Immunol; 1986 May; 16(1):69-80. PubMed ID: 2423487
[TBL] [Abstract][Full Text] [Related]
55. HLA-DR and DQ DNA polymorphisms in subjects of Asian Indian and white Caucasian origin.
Fletcher J; Mijovic C; Odugbesan O; Mackay E; Bradwell AR; Barnett AH
Mol Immunol; 1988 Apr; 25(4):411-7. PubMed ID: 2899839
[TBL] [Abstract][Full Text] [Related]
56. MHC class II sequences of an HLA-DR2 narcoleptic.
Lock CB; So AK; Welsh KI; Parkes JD; Trowsdale J
Immunogenetics; 1988; 27(6):449-55. PubMed ID: 3259543
[TBL] [Abstract][Full Text] [Related]
57. HLA-DQ molecular heterogeneity in HLA-DR4-Dw4 consanguineous cell lines.
Fernandez N; Labeta M; Kurpisz M; Solana R; Festenstein H
Dis Markers; 1986 Jun; 4(1-2):191-8. PubMed ID: 3502560
[TBL] [Abstract][Full Text] [Related]
58. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
59. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype.
Hillert J; Olerup O
Neurology; 1993 Jan; 43(1):163-8. PubMed ID: 8093808
[TBL] [Abstract][Full Text] [Related]
60. An antiviral T-cell clone defines a functional supertypic specificity shared by different HLA-DR molecules from DR2-short, DRw11, and DRw13 haplotypes.
Zeliszewski D; Sterkers G; Choppin J; Freidel C; Gebuhrer L; Betuel H; Levy JP
Immunogenetics; 1987; 25(2):84-90. PubMed ID: 3493215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
